Clinical Psychiatry News - FDA warns manufacturers about ADHD drug claims
Monday, January 12th, 2009 The Food and Drug Administration has warned five manufacturers of drugs for attention-deficit/hyperactivity disorder against using what it terms “false or misleading” promotional materials that overstate the drugs’ efficacy and downplay risks.
The warnings, contained in letters sent in late September to the makers of Adder-all XR, …
